MNPR
Price
$31.73
Change
-$0.66 (-2.04%)
Updated
May 30 closing price
Capitalization
194.04M
QNCX
Price
$1.04
Change
-$0.00 (-0.00%)
Updated
May 30 closing price
Capitalization
47.29M
72 days until earnings call
Interact to see
Advertisement

MNPR vs QNCX

Header iconMNPR vs QNCX Comparison
Open Charts MNPR vs QNCXBanner chart's image
Monopar Therapeutics
Price$31.73
Change-$0.66 (-2.04%)
Volume$17.08K
Capitalization194.04M
Quince Therapeutics
Price$1.04
Change-$0.00 (-0.00%)
Volume$102.29K
Capitalization47.29M
MNPR vs QNCX Comparison Chart
Loading...
MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MNPR vs. QNCX commentary
Jun 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNPR is a Buy and QNCX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 01, 2025
Stock price -- (MNPR: $31.73 vs. QNCX: $1.04)
Brand notoriety: MNPR and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNPR: 83% vs. QNCX: 32%
Market capitalization -- MNPR: $194.04M vs. QNCX: $47.29M
MNPR [@Biotechnology] is valued at $194.04M. QNCX’s [@Biotechnology] market capitalization is $47.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $303.58B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNPR’s FA Score shows that 0 FA rating(s) are green whileQNCX’s FA Score has 0 green FA rating(s).

  • MNPR’s FA Score: 0 green, 5 red.
  • QNCX’s FA Score: 0 green, 5 red.
According to our system of comparison, MNPR is a better buy in the long-term than QNCX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNPR’s TA Score shows that 4 TA indicator(s) are bullish while QNCX’s TA Score has 5 bullish TA indicator(s).

  • MNPR’s TA Score: 4 bullish, 5 bearish.
  • QNCX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, QNCX is a better buy in the short-term than MNPR.

Price Growth

MNPR (@Biotechnology) experienced а -10.49% price change this week, while QNCX (@Biotechnology) price change was -6.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.39%. For the same industry, the average monthly price growth was +0.48%, and the average quarterly price growth was -5.03%.

Reported Earning Dates

MNPR is expected to report earnings on Mar 31, 2025.

QNCX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+1.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNPR($194M) has a higher market cap than QNCX($47.3M). MNPR YTD gains are higher at: 44.227 vs. QNCX (-44.385). MNPR has higher annual earnings (EBITDA): -7M vs. QNCX (-33.93M). QNCX has more cash in the bank: 47.8M vs. MNPR (6.02M). MNPR has less debt than QNCX: MNPR (0) vs QNCX (15.4M). MNPR (0) and QNCX (0) have equivalent revenues.
MNPRQNCXMNPR / QNCX
Capitalization194M47.3M410%
EBITDA-7M-33.93M21%
Gain YTD44.227-44.385-100%
P/E RatioN/AN/A-
Revenue00-
Total Cash6.02M47.8M13%
Total Debt015.4M-
FUNDAMENTALS RATINGS
QNCX: Fundamental Ratings
QNCX
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MNPRQNCX
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
Bullish Trend 11 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VSCO21.210.50
+2.41%
Victoria's Secret & Co
PCAR93.85-0.44
-0.47%
PACCAR
SM23.42-0.38
-1.60%
SM Energy Company
HBB18.27-0.35
-1.88%
Hamilton Beach Brands Holding Company
IPSC0.53-0.03
-4.78%
Century Therapeutics

MNPR and

Correlation & Price change

A.I.dvisor tells us that MNPR and QNCX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MNPR and QNCX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNPR
1D Price
Change %
MNPR100%
-2.04%
QNCX - MNPR
33%
Poorly correlated
N/A
CVKD - MNPR
29%
Poorly correlated
-0.26%
AKBLF - MNPR
29%
Poorly correlated
+4.01%
LOGC - MNPR
28%
Poorly correlated
+1.11%
BDRX - MNPR
26%
Poorly correlated
+1.89%
More

QNCX and

Correlation & Price change

A.I.dvisor tells us that QNCX and CCCC have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that QNCX and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
N/A
CCCC - QNCX
33%
Poorly correlated
-5.30%
MNPR - QNCX
33%
Poorly correlated
-2.04%
ADCT - QNCX
31%
Poorly correlated
+11.55%
CLNN - QNCX
29%
Poorly correlated
+16.42%
KOD - QNCX
28%
Poorly correlated
-4.76%
More